| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Crispr Therapeutics AG (CRSP) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 20 sells. CRSP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 255.5K | $13.89M | - | |
| Dir | 22.0K | $1.20M | - | |
| CFO | 19.5K | $1.06M | - | |
| Other | 19.4K | $1.05M | -3,786 | |
| Other | 17.0K | $924.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 30, 2020 | Novak Rodger75 | President | Sale+OE | 100,000 | $125.00 | $12,500,000.00 | -7.2% | |
| Oct 9, 2020 | Novak Rodger75 | President | Sale+OE | 25,000 | $100.00 | $2,500,000.00 | -1.9% | |
| Sep 18, 2020 | Bolzon Bradley J Phd75 | Director | Sell | 3,035 | $86.87 | $263,635.88 | -0.6% | |
| Sep 16, 2020 | Bolzon Bradley J Phd75 | Director | Sell | 8,965 | $86.98 | $779,777.49 | -1.7% | |
| Sep 14, 2020 | Bolzon Bradley J Phd75 | Director | Sell | 1,155 | $84.89 | $98,045.29 | -0.2% | |
| Sep 10, 2020 | Bolzon Bradley J Phd75 | Director | Sell | 22,845 | $85.36 | $1,949,996.35 | -2.1% | |
| Sep 1, 2020 | Novak Rodger75 | President | Sale+OE | 25,000 | $92.62 | $2,315,577.70 | -1.3% | |
| Sep 1, 2020 | Tomsicek Michael John | Chief Financial Officer | Sale+OE | 12,000 | $92.26 | $1,107,068.00 | -47.6% | |
| Sep 1, 2020 | Bolzon Bradley J Phd75 | Director | Sale+OE | 60,000 | $92.51 | $5,550,644.20 | -44.4% | |
| Aug 19, 2020 | Novak Rodger75 | President | Sale+OE | 25,000 | $100.00 | $2,500,000.00 | -3.7% |